A complex signature network that controls the upregulation of PRMT5 in colorectal cancer

A complex signature network that controls the upregulation of PRMT5 in colorectal cancer

Bibliographic Details
Main Authors:	Han Wei, Antja-Voy Hartley, Aishat Motolani, Guanglong Jiang, Ahmad Safa, Lakshmi Prabhu, Yunlong Liu, Tao Lu
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2022-03-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304221001252

Similar Items

Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer
by: Antja-Voy Hartley, et al.
Published: (2020-05-01)

The Structure and Functions of PRMT5 in Human Diseases
by: Aishat Motolani, et al.
Published: (2021-10-01)

Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue
by: Lakshmi Prabhu, et al.
Published: (2023-01-01)

PRMT5 is a therapeutic target in choroidal neovascularization
by: Anbukkarasi Muniyandi, et al.
Published: (2023-01-01)

Using VBIM Technique to Discover ARMC4/ODAD2 as a Novel Negative Regulator of NF-κB and a New Tumor Suppressor in Colorectal Cancer
by: Matthew Martin, et al.
Published: (2022-03-01)

Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer
by: Aishat Motolani, et al.
Published: (2023-09-01)

The Pivotal Player: Components of NF-κB Pathway as Promising Biomarkers in Colorectal Cancer
by: Matthew Martin, et al.
Published: (2021-07-01)

Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5
by: Melody D. Fulton, et al.
Published: (2022-01-01)

Phosphorylation of the Regulators, a Complex Facet of NF-κB Signaling in Cancer
by: Aishat Motolani, et al.
Published: (2020-12-01)

Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation
by: Parisa Dashti, et al.
Published: (2023-12-01)

Understanding the role of PRMT5 in neuroblastoma
by: Albayrak, G
Published: (2023)

The Role of PRMT5 in Immuno-Oncology
by: Yoshinori Abe, et al.
Published: (2023-03-01)

Prmt1 upregulated by Hdc deficiency aggravates acute myocardial infarction via NETosis
by: Zhiwei Zhang, et al.
Published: (2022-04-01)

The PRMT5/WDR77 complex restricts hepatitis E virus replication.
by: Xiaohui Ju, et al.
Published: (2023-06-01)

Pan-cancer analysis identifies protein arginine methyltransferases PRMT1 and PRMT5 and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma
by: Jia Wang, et al.
Published: (2023-12-01)

PRMT5: An Emerging Target for Pancreatic Adenocarcinoma
by: Michael K. C. Lee, et al.
Published: (2021-10-01)

PRMT5 Inhibitors in Merkel Cell Carcinoma
by: Higgins, Kathleen Whitmore
Published: (2024)

Mechanisms and consequences of resistance to PRMT5 Inhibition
by: Mueller, Helen S.
Published: (2022)

Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancer
by: Yao Shen, et al.
Published: (2022-12-01)

Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells
by: Shayaan Rasheed, et al.
Published: (2023-03-01)

The Role of the PRMT5–SND1 Axis in Hepatocellular Carcinoma
by: Tanner Wright, et al.
Published: (2021-01-01)

Autophagy dictates sensitivity to PRMT5 inhibitor in breast cancer
by: Charles Brobbey, et al.
Published: (2023-07-01)

PRMT5 promotes chemotherapy‐induced neuroendocrine differentiation in NSCLC
by: Qi Shen, et al.
Published: (2023-06-01)

The Prmt5-Vasa module is essential for spermatogenesis in Bombyx mori.
by: Xu Yang, et al.
Published: (2023-01-01)

PRMT5-mediated regulatory arginine methylation of RIPK3
by: Chanchal Chauhan, et al.
Published: (2023-01-01)

The crescent-like Golgi ribbon is shaped by the Ajuba/PRMT5/Aurora-A complex-modified HURP
by: Shao-Chih Chiu, et al.
Published: (2023-06-01)

The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease
by: Emily Sun, et al.
Published: (2022-08-01)

Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment
by: Faranak Alipourgivi, et al.
Published: (2023-12-01)

ZEB2/TWIST1/PRMT5/NuRD Multicomplex Contributes to the Epigenetic Regulation of EMT and Metastasis in Colorectal Carcinoma
by: Yayuan Zheng, et al.
Published: (2022-07-01)

PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis
by: Hao Liu, et al.
Published: (2024-02-01)

Investigation of the biological function of arginine methyltransferase PRMT5 in human cancers
by: Jin, L
Published: (2020)

Therapeutic targeting of PRMT5 and mutant ACVR1 in paediatric glioma
by: Brown, EJ
Published: (2021)

PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma
by: Devendra Kumar, et al.
Published: (2023-12-01)

KAP1 is a Novel Substrate for the Arginine Methyltransferase PRMT5
by: Roberta di Caprio, et al.
Published: (2015-01-01)

Characterization of protein arginine methyltransferase of TgPRMT5 in Toxoplasma gondii
by: Min Liu, et al.
Published: (2019-05-01)

Structure, Activity, and Function of PRMT1
by: Charlène Thiebaut, et al.
Published: (2021-10-01)

PRMT5 inhibition reduces viability and stemness of pediatric high grade glioma
by: Brown, EJ, et al.
Published: (2021)

TRAF6 Promotes PRMT5 Activity in a Ubiquitination-Dependent Manner
by: Liu Liu, et al.
Published: (2023-04-01)

Linking PRMT5 to breast cancer stem cells: New therapeutic opportunities?
by: Kelly Chiang, et al.
Published: (2018-05-01)

Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel
by: Mueller, Helen S, et al.
Published: (2022)